Cargando…

Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

BACKGROUND: Nemolizumab is deemed as a promising drug for atopic dermatitis (AD) patients with pruritus. OBJECTIVE: This study aimed to evaluate the efficacy of nemolizumab in treating patients with AD and the association between the dosage or regimen of nemolizumab with the improvement in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Junqin, Hu, Fengxia, Dan, Maoli, Sang, Yingbing, Abulikemu, Kailibinuer, Wang, Qian, Hong, Yongzhen, Kang, Xiaojing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086972/ https://www.ncbi.nlm.nih.gov/pubmed/35558086 http://dx.doi.org/10.3389/fimmu.2022.825312

Ejemplares similares

Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
por: Sidbury, Robert, et al.
Publicado: (2022)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial
por: Kabashima, Kenji, et al.
Publicado: (2023)

Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long‐term studies
por: Kabashima, K., et al.
Publicado: (2021)

Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study
por: Mihara, Ryosuke, et al.
Publicado: (2019)

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Ruxolitinib Cream Has Dual Efficacy on Pruritus and Inflammation in Experimental Dermatitis
por: Scuron, Monika D., et al.
Publicado: (2021)

Neuroimmunological Mechanism of Pruritus in Atopic Dermatitis Focused on the Role of Serotonin
por: Kim, Kwangmi
Publicado: (2012)

The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus
por: Rerknimitr, Pawinee, et al.
Publicado: (2017)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Neurogenic markers of the inflammatory process in atopic dermatitis: relation to the severity and pruritus
por: Teresiak-Mikołajczak, Ewa, et al.
Publicado: (2013)

Transcutaneous Slowly Depolarizing Currents Elicit Pruritus in Patients with Atopic Dermatitis
por: RUKWIED, Roman, et al.
Publicado: (2020)

Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Pathomechanism of Pruritus in Psoriasis and Atopic Dermatitis: Novel Approaches, Similarities and Differences
por: Kaczmarska, Agnieszka, et al.
Publicado: (2023)

Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study
por: Kinugasa, Eriko, et al.
Publicado: (2021)

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
por: Ständer, S., et al.
Publicado: (2022)

The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis
por: Zhang, Yan, et al.
Publicado: (2022)

The Suppressive Effect of Mamiran Cream on Atopic Dermatitis-Like Skin Lesions In Vivo
por: Aierken, Kailibinuer, et al.
Publicado: (2021)

Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis
por: Eichenfield, Lawrence F., et al.
Publicado: (2020)

The Anti-Inflammatory and Anti-Pruritus Mechanisms of Huanglian Jiedu Decoction in the Treatment of Atopic Dermatitis
por: Xu, Yubin, et al.
Publicado: (2021)

Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome
por: Kawakami, Toshiaki, et al.
Publicado: (2015)

Efficacy of topical and systemic treatments for atopic dermatitis on pruritus: A systematic literature review and meta-analysis
por: Rodriguez-Le Roy, Youna, et al.
Publicado: (2022)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

Toll-like receptors: their roles in pathomechanisms of atopic dermatitis
por: Tamagawa-Mineoka, Risa
Publicado: (2023)

Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
por: Isaifan, Dina, et al.
Publicado: (2023)

Formaldehyde-Induced Aggravation of Pruritus and Dermatitis Is Associated with the Elevated Expression of Th1 Cytokines in a Rat Model of Atopic Dermatitis
por: Han, Rafael Taeho, et al.
Publicado: (2016)

New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration
por: Qi, Hong-jiao, et al.
Publicado: (2021)

Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis
por: Hulshof, Lies, et al.
Publicado: (2018)

Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
por: Humeau, Mélanie, et al.
Publicado: (2022)

Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis
por: Joshi, Aaroh Anand, et al.
Publicado: (2023)

Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis
por: Xia, Dengmei, et al.
Publicado: (2022)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
por: Zheng, Chunjiao, et al.
Publicado: (2023)

Effect of Resveratrol-Enriched Rice on Skin Inflammation and Pruritus in the NC/Nga Mouse Model of Atopic Dermatitis
por: Kang, Min Cheol, et al.
Publicado: (2019)

Inhibition of thymic stromal lymphopoietin production to improve pruritus and quality of life in infants and children with atopic dermatitis
por: Fitoussi, Julie, et al.
Publicado: (2020)

Relationship Among Treatment, Pruritus, Investigator’s Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis
por: Simpson, Eric L., et al.
Publicado: (2021)

The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis
por: Malinowska, Karolina, et al.
Publicado: (2019)

Establishment of an Intradermal Canine IL-31-Induced Pruritus Model to Evaluate Therapeutic Candidates in Atopic Dermatitis
por: Pearson, Jason, et al.
Publicado: (2023)

Scratching increases epidermal neuronal branching and alters psychophysical testing responses in atopic dermatitis and brachioradial pruritus
por: Renkhold, Lina, et al.
Publicado: (2023)

Management of atopic dermatitis: safety and efficacy of phototherapy
por: Patrizi, Annalisa, et al.
Publicado: (2015)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pu91p1aqk4lhls8di17ml8ngio